215732-94-8 Usage
Uses
Used in Pharmaceutical Industry:
2,2,3,3-Tetrafluoro-6-nitrilobenzodioxene is used as a key intermediate for the production of pharmaceuticals. Its unique structure and properties make it suitable for the synthesis of various drug molecules, contributing to the development of new medications with improved therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, 2,2,3,3-Tetrafluoro-6-nitrilobenzodioxene is utilized as an intermediate in the synthesis of agrochemicals. Its incorporation into these products helps enhance their effectiveness in protecting crops from pests and diseases, thereby increasing agricultural productivity.
Used in Dye Industry:
2,2,3,3-Tetrafluoro-6-nitrilobenzodioxene is employed as a building block in the production of dyes. Its chemical properties allow for the creation of dyes with specific color characteristics and improved stability, catering to the diverse requirements of various industries such as textiles, plastics, and printing.
Used in Material Science:
2,2,3,3-Tetrafluoro-6-nitrilobenzodioxene has potential applications in the field of material science. It serves as a valuable building block for the synthesis of polymers and other advanced materials, enabling the development of innovative materials with enhanced properties and performance for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 215732-94-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,5,7,3 and 2 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 215732-94:
(8*2)+(7*1)+(6*5)+(5*7)+(4*3)+(3*2)+(2*9)+(1*4)=128
128 % 10 = 8
So 215732-94-8 is a valid CAS Registry Number.
215732-94-8Relevant academic research and scientific papers
HETEROBICYCLIC METALLOPROTEASE INHIBITORS
-
Page/Page column 158, (2008/06/13)
The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP- 13 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP- 13 inhibitors.
